GC31695
Acrivastine
Also listed as Acrivastine (BW825C)
Acrivastine (BW825C) (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis
ChemicalCAS87848-99-5MW348.44FormulaC22H24N2O2
- CAS number
- 87848-99-5
- Molecular weight
- 348.44
- Formula
- C22H24N2O2
- Solubility
- DMSO ： 10·45 mg/mL (29·99 mM)
- InChIKey
- PWACSDKDOHSSQD-IUTFFREVSA-N
- Catalogue number
- GC31695
- Brand
- GLPBIO
Computed properties PubChem CID 5284514 · XLogP 1.6 · TPSA 53.4 Ų · H-bond donors 1
- XLogP
- 1.6
- TPSA
- 53.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 6
- Heavy atoms
- 26
SMILES CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC(=N3)/C=C/C(=O)O
Computed descriptors from PubChem (CID 5284514), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il